Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
The Need for a Consensus
Veeva Vault CTMS Gains Momentum as Industry Moves to Unify Clinical Applications and Processes
CTMS cloud application streamlines trial management and delivers end-to-end visibility of clinical trials on one platform
Nicox receives FDA approval of ZERVIATE (cetirizine ophthalmic solution) 0.24%
ZERVIATE was established in three randomized, double-masked, placebo-controlled, conjunctival antigen challenge (Ora-CAC®3 model of allergic conjunctivitis)
Recognizing Additional Value in China
Ophthalmic Product Development Insights
Dry Eye: Beyond the Usual Suspects
Digging deeper into the types of patients who get dry eye and the situations that can bring it on.
Ocular Gene Therapy Trials Advance
Results of the first phase 3 trial in this field were announced.
Okogen Secures Ora to Conduct Clinical and Regulatory Development of OKG-0301 for Adenoviral Conjunctivitis
Okogen, Inc. to present at 2017 Biotech Showcase